Dosage Forms

Reshaping Dosage Forms

Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Frontrunners in Bispecific Antibodies

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Improving Inhaled-Product Testing

April 18, 2013

The challenge of developing orally inhaled nasal drug products (OINDPs) is complicated by the interplay between drug-delivery devices and formulation.

FDA Will Not Approve Generics to Original OxyContin

April 17, 2013

The FDA approved updated labeling for Purdue Pharma L.P.?s reformulated OxyContin tablets, but also determined that it will not approve generic versions of the original OxyContin.

High-Efficiency Bohle Tablet Coater

April 15, 2013

FLUID-BAG MULTI - containers for liquid and semi-solid pharmaceuticals

April 12, 2013

State Legislatures Become Battlegrounds for Biosimilars

April 11, 2013

Maryland is the latest state to consider whether to include additional requirements for substitution of biological products

Lyophilization Technology: Slow Progress but Hopeful Outlook

April 10, 2013

As an important method for improving the stability of parenterals, lyophilization is fairly well understood, but can still benefit from several advancements in the technology.

Media Makers Focus on Quality

April 10, 2013

With high productivity achieved, makers of cell-culture media are working to optimize product quality through better understanding and control of raw materials and production processes.

Ignorance is Bliss in Solid Dosage Taste-Masking

April 10, 2013

The trick to taste-masking in solid dosage forms is to never let the taste buds have a chance.

Teva and Lonza Review Biosimilars Opportunity

April 08, 2013

Teva and Lonza have announced that their joint venture will continue to develop, manufacture and market affordable, efficacious and safe biosimilars.

Process Analytical Technology and Process Control in Solid-Dosage Manufacturing

April 02, 2013

Industry is moving toward closed-loop control of continuous processing.